After the Moore case, Congress held hearings and commissioned reports that uncovered the millions of dollars being made from human tissue research, and it formed a special committee to assess the situation and recommend how to proceed. Its findings: the use of human cells and tissues in biotechnology holds “great promise” for improving human health, but raises extensive ethical and legal questions that “have not been answered” and to which “no single body of law, policy or ethics applies.” This, they said, must be clarified.
